Biotechs Report Regulatory Headaches, High-Stakes Catalysts During Q4 Earnings

By /

Dozens of biotechs reported earnings this week. BioSpace recaps key highlights from Capricor Therapeutics, Legend Biotech, Inovio and Allogene.

Scroll to Top